ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

ClinicalTrials.gov ID: NCT00226668

Public ClinicalTrials.gov record NCT00226668. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 2:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Double-Blind Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Dexamethasone for Control of Symptoms Associated With Peritumoral Brain Edema in Patients With Primary Malignant Glioma

Study identification

NCT ID
NCT00226668
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celtic Pharma Development Services
Industry
Enrollment
120 participants

Conditions and interventions

Interventions

  • hCRF Drug
  • placebo hCRF Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2005
Primary completion
Not listed
Completion
Dec 31, 2007
Last update posted
Jan 2, 2008

2006 – 2008

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013
UC San Diego Cancer Center La Jolla California 92093
Hoag Memorial Hospital Presbyterian Newport Beach California 92658
Stanford University Medical Center Palo Alto California 94305
UC Davis Medical Center Sacramento California 95817
University of Colorado Cancer Center Aurora Colorado 80045
Moffitt Cancer Center and Research Tampa Florida 33612
Winship Cancer Institute, Emory University Atlanta Georgia 30322
Northwestern University, Feinberg School of Medicine Chicago Illinois 60611
Evanston Northwestern Healthcare Evanston Illinois 60201
Beth Israel Deaconess Med Center Boston Massachusetts 02215
Field Neurosciences Institute Saginaw Michigan 48604
Neurology Group of Bergen County Ridgewood New Jersey 07450
Dent Neurologic Institute Amherst New York 14226
Weill Medical College of Cornell University New York New York 10021
Wake Forest University Winston-Salem North Carolina 27106
University Hematology Oncology Care, LLC Cincinnati Ohio 43210
Good Samaritan Hospital Cincinnati Ohio 45220
The Ohio State University Columbus Ohio 43210
Oregon Clinic Portland Oregon 97210
Methodist Healthcare - University Hospital Memphis Tennessee 38103
Vanderbilt University Medical Center Nashville Tennessee 37232
University of Wisconsin Madison Wisconsin 53792
Medical College of Wisconsin Milwaukee Wisconsin 53226-3596

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00226668, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 2, 2008 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00226668 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →